Clinical Trials

73 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT04914676 2025-01-16

Accelerated Dose Schedule of Cytarabine Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) in Complete Remission

5 enrolled 9 charts

Leukemia, Myeloid, Acute

NCT04526795 2024-12-12

Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia

LymphoidMyeloidOther hematologic neoplasm

19 enrolled

Blast Crisis, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, T-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05601466 2024-11-06

Natural Killer(NK) Cell Therapy for Acute Myeloid Leukemia

3 enrolled

Leukemia, Myeloid, Acute

NCT05601830 2024-11-06

Natural Killer(NK) Cell Therapy for AML Minimal Residual Disease

1 enrolled

Tumor-Agnostic

Neoplasm, Residual

NCT03488225 2024-07-16

Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia

4 enrolled 11 charts

Burkitt Lymphoma

NCT04526288 2024-05-23

CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease

1 enrolled 6 charts

Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute

NCT01186328 2024-02-01

EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)

6 enrolled 11 charts

Leukemia, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT04196010 2023-12-28

Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms

13 enrolled

Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute

NCT03904251 2023-11-18

CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia

13 enrolled

Leukemia, Leukemia, Myeloid, Acute

NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

CNSClassical hematologyLymphoid

17 enrolled 7 charts

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT03634228 2023-06-15

Milademetan Tosylate and Low-Dose Cytarabine With or Without Venetoclax in Treating Participants With Recurrent or Refractory Acute Myeloid Leukemia

16 enrolled 13 charts

Leukemia, Myeloid, Acute

NCT01005914 2023-01-06

Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

11 enrolled 6 charts

Leukemia, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT03518112 2022-11-04

Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia

6 enrolled 10 charts

Burkitt Lymphoma

NCT03988205 2022-07-19

Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia

Phase 4 Terminated

3 enrolled 10 charts

Leukemia, Leukemia, Myeloid, Acute

NCT04326439 2022-06-15

AflacLL1901 (CHOA-AML)

8 enrolled 12 charts

Leukemia, Myeloid, Acute

NCT02043587 2022-05-02

Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma

31 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02927938 2022-04-21

Leukemia Stem Cell Detection in Acute Myeloid Leukemia

18 enrolled 25 charts

Leukemia, Myeloid, Acute

NCT01876953 2022-03-31

Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia

20 enrolled 9 charts

Congenital Abnormalities, Leukemia, Myeloid, Acute

NCT03519984 2021-11-30

EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia

LymphoidMyeloidOther hematologic neoplasm

3 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT01246752 2021-10-29

AML

143 enrolled

Leukemia, Leukemia, Myeloid, Acute

NCT01158885 2021-10-26

Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia

2 enrolled 7 charts

Recurrence, Leukemia, Myeloid, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02298166 2021-10-06

Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations

9 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT02105116 2021-08-24

AML Therapy With Irradiated Allogeneic Cells

Phase NA Terminated

6 enrolled 6 charts

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT02229266 2021-08-16

HINKL

1 enrolled

Leukemia, Myeloid, Acute

NCT02440568 2021-07-06

AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients

22 enrolled 17 charts

Leukemia, Myeloid, Acute

NCT00439296 2021-03-17

ABT-751 With Chemotherapy for Relapsed Pediatric ALL

9 enrolled 12 charts

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02483000 2020-11-23

Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies

3 enrolled 12 charts

Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT01656252 2020-11-03

PrE0901

Classical hematologyOther hematologic neoplasm

15 enrolled 5 charts

Jacobs syndrome, Pathologic Complete Response, Leukemia, Thrombocytopenia, Leukemia, Myeloid, Acute

NCT03071276 2020-05-22

Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia

37 enrolled 11 charts

Leukemia, Myeloid, Acute

NCT00632827 2020-04-27

Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)

21 enrolled 13 charts

Lymphoma, T-Cell, Peripheral

NCT01636609 2020-04-13

Tosedostat and Cytarabine or Azacitidine in Treating Older Participants With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

18 enrolled

Leukemia, Myeloid, Acute

NCT02109627 2020-03-24

Ficlatuzumab With High Dose Cytarabine in Relapsed and Refractory AML

17 enrolled

Leukemia, Myeloid, Acute

NCT00939653 2020-02-19

T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML)

6 enrolled 10 charts

Recurrence, Leukemia, Myeloid, Acute

NCT01408160 2019-09-06

Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

18 enrolled

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02535806 2019-08-13

Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults

2 enrolled 11 charts

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03735446 2019-06-12

Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial

MyeloidOther hematologic neoplasm

2 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03381118 2019-04-05

Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients

16 enrolled

Leukemia, Myeloid, Acute

NCT02518750 2019-04-03

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma

3 enrolled 6 charts

Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00928200 2019-02-19

Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)

1 enrolled 7 charts

Hypersensitivity, Leukemia, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01849276 2019-01-31

Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML

2 enrolled 9 charts

Congenital Abnormalities, Blast Crisis, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT02412475 2019-01-24

Epigenetic Reprogramming in Relapse AML

3 enrolled

Leukemia, Myeloid, Acute

NCT02008006 2019-01-08

BENEFIT

21 enrolled